Sheaff Brock Investment Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-1,649
Closed -$207K 592
2021
Q3
$207K Hold
1,649
0.02% 486
2021
Q2
$223K Sell
1,649
-150
-8% -$19.7K 0.02% 443
2021
Q1
$244K Sell
1,799
-233
-11% -$34.9K 0.02% 400
2020
Q4
$286K Sell
2,032
-50
-2% -$6.4K 0.02% 344
2020
Q3
$232K Buy
2,082
+20
+1% +$2.24K 0.02% 356
2020
Q2
$231K Buy
+2,062
New +$203K 0.02% 355
2019
Q3
Sell
-2,587
Closed -$227K 502
2019
Q2
$227K Sell
2,587
-23
-0.9% -$1.96K 0.02% 397
2019
Q1
$236K Buy
+2,610
New +$222K 0.03% 399
2018
Q4
Sell
-3,494
Closed -$335K 535
2018
Q3
$335K Buy
3,494
+432
+14% +$41.9K 0.03% 337
2018
Q2
$291K Buy
3,062
+1
+0% +$92 0.03% 371
2018
Q1
$269K Buy
3,061
+110
+4% +$10K 0.03% 382
2017
Q4
$250K Sell
2,951
-395
-12% -$33.1K 0.03% 392
2017
Q3
$290K Buy
+3,346
New +$268K 0.04% 366
2017
Q1
Sell
-3,611
Closed -$214K 642
2016
Q4
$214K Buy
3,611
+351
+11% +$21.7K 0.03% 496
2016
Q3
$216K Sell
3,260
-450
-12% -$27.8K 0.03% 451
2016
Q2
$201K Buy
+3,710
New +$203K 0.03% 485
2016
Q1
Sell
-3,610
Closed -$253K 694
2015
Q4
$253K Buy
+3,610
New +$246K 0.03% 459

Other funds holding XBI

Sheaff Brock Investment Advisors's XBI Position: Q4 2021 in Review

Sheaff Brock Investment Advisors sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2021, closing a stake of 1,649 shares — an estimated $207K sold.

Sheaff Brock Investment Advisors first reported a position in XBI in Q4 2015 and held it in 17 quarters. The position peaked at $335K in Q3 2018. 702 funds tracked by Wall St. Rank hold XBI as of Q4 2021.

  • Sheaff Brock Investment Advisors reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2021 after selling out during the quarter.
  • Sheaff Brock Investment Advisors sold 1,649 State Street SPDR S&P Biotech ETF shares in Q4 2021, an estimated $207K.
  • Sheaff Brock Investment Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q4 2015 and held it in 17 quarters.
  • Sheaff Brock Investment Advisors's State Street SPDR S&P Biotech ETF position peaked at $335K in Q3 2018.
  • 702 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2021.

Based on Sheaff Brock Investment Advisors's 13F filing for Q4 2021, filed 3 Feb 2022.